Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is one of the world's top ten most common cancers. Current survival rates are poor with only 50% of patients expected to survive five years after diagnosis. The poor survival rate of HNSCC is partly attributable to the tendency for diagnosis at the...
Saved in:
Main Authors: | Aidan G. Major (Author), Luke P. Pitty (Author), Camile S. Farah (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer stem cells in head and neck squamous cell carcinoma
by: Harish A Kumar, et al.
Published: (2023) -
Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma-Treatment Modalities
by: Zisis Vasileios, et al.
Published: (2021) -
Effect of resveratrol and oxyresveratrol on deferoxamine-induced cancer stem cell marker expression in human head and neck squamous cell carcinoma
by: Artid Amorntaveechai, et al.
Published: (2022) -
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
by: Stefano Cavalieri, et al.
Published: (2021) -
ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma
by: Jianmin Liu, et al.
Published: (2024)